Advertisement
Oral and Maxillofacial Pathology| Volume 93, ISSUE 1, P56-74, January 2002

Advanced diagnostic methods in oral and maxillofacial pathology. Part II: Immunohistochemical and immunofluorescent methods

      Abstract

      The practice of pathology is currently undergoing significant change, in large part due to advances in the analysis of DNA, RNA, and proteins in tissues. These advances have permitted improved biologic insights into many developmental, inflammatory, metabolic, infectious, and neoplastic diseases. Moreover, molecular analysis has also led to improvements in the accuracy of disease diagnosis and classification. It is likely that, in the future, these methods will increasingly enter into the day-to-day diagnosis and management of patients. The pathologist will continue to play a fundamental role in diagnosis and will likely be in a pivotal position to guide the implementation and interpretation of these tests as they move from the research laboratory into diagnostic pathology. The purpose of this 2-part series is to provide an overview of the principles and applications of current molecular biologic and immunologic tests. In Part I, the biologic fundamentals of DNA, RNA, and proteins and methods that are currently available or likely to become available to the pathologist in the next several years for their isolation and analysis in tissue biopsies were discussed. In Part II, advances in immunohistochemistry and immunofluorescence methods and their application to modern diagnostic pathology are reviewed. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;93:56-74)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Pettigrew NM.
        Techniques in immunocytochemistry. Appli-cation to diagnostic pathology.
        Arch Pathol Lab Med. 1989; 113: 641-644
        • Werner M
        • Chott A
        • Fabiano A
        • Battifora H.
        Effect of formalin tissue fixation and processing on immunohistochemistry.
        Am J Surg Pathol. 2000; 24: 1016-1019
        • Shi SR
        • Key ME
        • Kalra KL.
        Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.
        J Histochem Cytochem. 1991; 39: 741-748
        • Shi SR
        • Chaiwun B
        • Young L
        • Cote RJ
        • Taylor CR.
        Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections.
        J Histochem Cytochem. 1993; 41: 1599-1604
        • Gatter KC
        • Alcock C
        • Heryet A
        • Mason DY.
        Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques.
        Lancet. 1985; 1: 1302-1305
        • Leong AS
        • Wannakrairot A.
        A retrospective analysis of immunohistochemical staining in identification of poorly differentiated round cell and spindle cell tumors—results, reagents and costs.
        Pathology. 1992; 24: 254-260
        • Moll R
        • Franke WW
        • Schiller DL
        • Geiger B
        • Krepler R.
        The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells.
        Cell. 1982; 31: 11-24
        • Smedts F
        • Ramaekers F
        • Robben H
        • Pruszczynski M
        • van Muijen G
        • Lane B
        • et al.
        Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia.
        Am J Pathol. 1990; 136: 657-668
        • Vaidya MM
        • Borges AM
        • Pradhan SA
        • Rajpal RM
        • Bhisey AN.
        Altered keratin expression in buccal mucosal squamous cell carcinoma.
        J Oral Pathol Med. 1989; 18: 282-286
        • Heyden A
        • Huitfeldt HS
        • Koppang HS
        • Thrane PS
        • Bryne M
        • Brandtzaeg P.
        Cytokeratins as epithelial differentiation markers in premalignant and malignant oral lesions.
        J Oral Pathol Med. 1992; 21: 7-11
        • Zarbo RJ
        • Crissman JD
        • Venkat H
        • Weiss MA.
        Spindle-cell carcinoma of the upper aerodigestive tract mucosa. An immunohistologic and ultrastructural study of 18 biphasic tumors and comparison with seven monophasic spindle-cell tumors.
        Am J Surg Pathol. 1986; 10: 741-753
        • Dias P
        • Chen B
        • Dilday B
        • Palmer H
        • Hosoi H
        • Singh S
        • et al.
        Strong immunostaining for myogenin in rhabdomyosarcoma is significantly associated with tumors of the alveolar subclass.
        Am J Pathol. 2000; 156: 399-408
        • Gown AM
        • Vogel AM
        • Gordon D
        • Lu PL.
        A smooth muscle–specific monoclonal antibody recognizes smooth muscle actin isozymes.
        J Cell Biol. 1985; 100: 807-813
        • Regezi JA
        • Zarbo RJ
        • Stewart JC
        • Courtney RM.
        Polymorphous low-grade adenocarcinoma of minor salivary gland. A comparative histologic and immunohistochemical study.
        Oral Surg Oral Med Oral Pathol. 1991; 71: 469-475
        • Prasad AR
        • Savera AT
        • Gown AM
        • Zarbo RJ.
        The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
        Arch Pathol Lab Med. 1999; 123: 801-806
        • Nakazato Y
        • Ishida Y
        • Takahashi K
        • Suzuki K.
        Immunohisto-chemical distribution of S-100 protein and glial fibrillary acidic protein in normal and neoplastic salivary glands.
        Virchows Arch A Pathol Anat Histopathol. 1985; 405: 299-310
        • Chrysomali E
        • Papanicolaou SI
        • Dekker NP
        • Regezi JA.
        Benign neural tumors of the oral cavity: a comparative immunohistochemical study.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997; 84: 381-390
        • Nickoloff BJ.
        The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma.
        Arch Dermatol. 1991; 127: 523-529
        • Perez-Ordonez B
        • Koutlas IG
        • Strich E
        • Gilbert RW
        • Jordan RC.
        Solitary fibrous tumor of the oral cavity: an uncommon location for a ubiquitous neoplasm.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 87: 589-593
        • Friedman HD
        • Tatum AH.
        HMB-45–positive malignant lym-phoma. A case report with review of aberrant HMB-45 reactivity.
        Arch Pathol Lab Med. 1991; 115: 826-830
        • Hancock C
        • Allen BC
        • Herrera GA.
        HMB-45 detection in adenocarcinomas.
        Arch Pathol Lab Med. 1991; 115: 886-890
        • Busam KJ
        • Chen YT
        • Old LJ
        • Stockert E
        • Iversen K
        • Coplan KA
        • et al.
        Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
        Am J Surg Pathol. 1998; 22: 976-982
        • Andrade RE
        • Wick MR
        • Frizzera G
        • Gajl-Peczalska KJ.
        immunophenotyping of hematopoietic malignancies in paraffin sections.
        Human Pathol. 1988; 19: 394-402
        • Myskow MW
        • Krajewski AS
        • Salter DM
        • Dobson CM
        • Miller EP.
        Paraffin section immunophenotyping of non-Hodgkin's lymphoma, using a panel of monoclonal antibodies.
        Am J Clin Pathol. 1988; 90: 564-574
        • Regezi JA
        • Zarbo RJ
        • Stewart JC.
        Extranodal oral lymphomas. Histologic subtypes and immunophenotypes (in routinely processed tissue).
        Oral Surg Oral Med Oral Pathol. 1991; 72: 702-708
        • Astsaturov IA
        • Matutes E
        • Morilla R
        • Seon BK
        • Mason DY
        • Farahat N
        • et al.
        Differential expression of B29 (CD79b) and mb-1 (CD79a) proteins in acute lymphoblastic leukaemia.
        Leukemia. 1996; 10: 769-773
        • Mason DY
        • Cordell JL
        • Brown MH
        • Borst J
        • Jones M
        • Pulford K
        • et al.
        CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples.
        Blood. 1995; 86: 1453-1459
        • Jaffe ES.
        Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology.
        Mod Pathol. 2001; 14: 219-228
        • Bhatavdekar JM
        • Trivedi SN
        • Vora HH
        • Shukla SN.
        Usefulness of terminal deoxynucleotidyl transferase as prognosticator in leukemia patients.
        Int J Biol Markers. 1993; 8: 77-80
        • Drexler HG
        • Sperling C
        • Ludwig WD.
        Terminal deoxynucleotidyl transferase (TdT) expression in acute myeloid leukemia.
        Leukemia. 1993; 7: 1142-1150
        • Wiedenmann B
        • Franke WW
        • Kuhn C
        • Moll R
        • Gould VE.
        Synaptophysin: a marker protein for neuroendocrine cells and neoplasms.
        Proc Natl Acad Sci USA. 1986; 83: 3500-3504
        • Weidner N
        • Tjoe J.
        Immunohistochemical profile of mono-clonal antibody O13: antibody that recognizes glycoprotein p30/32MIC2 and is useful in diagnosing Ewing's sarcoma and peripheral neuroepithelioma.
        Am J Surg Pathol. 1994; 18: 486-494
        • Sandberg AA
        • Bridge JA.
        Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors.
        Cancer Genet Cytogenet. 2000; 123: 1-26
        • Chu P
        • Wu E
        • Weiss LM.
        Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases.
        Mod Pathol. 2000; 13: 962-972
        • Savera AT
        • Torres FX
        • Linden MD
        • Bacchi CE
        • Gown AM
        • Zarbo RJ.
        Primary versus metastatic pulmonary adenocarcinoma.
        Appl Immunohistochem. 1996; 4: 86-94
        • Bartkova J
        • Lukas J
        • Muller H
        • Strauss M
        • Gusterson B
        • Bartek J.
        Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.
        Cancer Res. 1995; 55: 949-956
        • Jordan RC
        • Bradley G
        • Slingerland J.
        Reduced levels of the cell-cycle inhibitor p27kip1 in epithelial dysplasia and carcinoma of the oral cavity.
        Am J Pathol. 1998; 152: 585-590
        • Michalides R
        • van Veelen N
        • Hart A
        • Loftus B
        • Wientjens E
        • Balm A.
        Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck.
        Cancer Res. 1995; 55: 975-978
        • Regezi JA
        • Dekker NP
        • McMillan A
        • Ramirez-Amador V
        • Meneses-Garcia A
        • Ruiz-Godoy Rivera LM
        • et al.
        p53, p21, Rb, and MDM2 proteins in tongue carcinoma from patients <35 versus >75 years.
        Oral Oncol. 1999; 35: 379-383
        • Schoelch ML
        • Regezi JA
        • Dekker NP
        • Ng IO
        • McMillan A
        • Ziober BL
        • et al.
        Cell cycle proteins and the development of oral squamous cell carcinoma.
        Oral Oncol. 1999; 35: 333-342
        • Pena JC
        • Thompson CB
        • Recant W
        • Vokes EE
        • Rudin CM.
        Bcl-xL and Bcl-2 expression in squamous cell carcinoma of the head and neck.
        Cancer. 1999; 85: 164-170
        • Schoelch ML
        • Le QT
        • Silverman Jr, S
        • McMillan A
        • Dekker NP
        • Fu KK
        • et al.
        Apoptosis-associated proteins and the development of oral squamous cell carcinoma.
        Oral Oncol. 1999; 35: 77-85
        • Guo B
        • Cao S
        • Toth K
        • Azrak RG
        • Rustum YM.
        Overexpression of Bax enhances antitumor activity of chemotherapeutic agents in human head and neck squamous cell carcinoma.
        Clin Cancer Res. 2000; 6: 718-724
        • Grandis JR
        • Melhem MF
        • Barnes EL
        • Tweardy DJ.
        Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck.
        Cancer. 1996; 78: 1284-1292
        • Grandis JR
        • Melhem MF
        • Gooding WE
        • Day R
        • Holst VA
        • Wagener MM
        • et al.
        Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival.
        J Natl Cancer Inst. 1998; 90: 824-832
        • Ke LD
        • Adler-Storthz K
        • Clayman GL
        • Yung AW
        • Chen Z.
        Differential expression of epidermal growth factor receptor in human head and neck cancers.
        Head Neck. 1998; 20: 320-327
        • Press MF
        • Pike MC
        • Hung G
        • Zhou JY
        • Ma Y
        • George J
        • et al.
        Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis.
        Cancer Res. 1994; 54: 5675-5682
        • Slamon DJ
        • Godolphin W
        • Jones LA
        • Holt JA
        • Wong SG
        • Keith DE
        • et al.
        Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.
        Science. 1989; 244: 707-712
        • Wong DT.
        TGF-alpha and oral carcinogenesis.
        Eur J Cancer B Oral Oncol. 1993; 29B: 3-7
        • Maiorano E
        • Favia G
        • Maisonneuve P
        • Viale G.
        Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa.
        J Pathol. 1998; 185: 167-174
        • Anderson JA
        • Irish JC
        • McLachlin CM
        • Ngan BY.
        H-ras oncogene mutation and human papillomavirus infection in oral carcinomas.
        Arch Otolaryngol Head Neck Surg. 1994; 120: 755-760
        • Eversole LR
        • Sapp JP.
        c-myc oncoprotein in oral precancerous and early cancerous lesions.
        Eur J Cancer B Oral Oncol. 1993; 29B: 131-135
        • Saranath D
        • Chang SE
        • Bhoite LT
        • Panchal RG
        • Kerr IB
        • Mehta AR
        • et al.
        High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India.
        Br J Cancer. 1991; 63: 573-578
        • Johansson N
        • Airola K
        • Grenman R
        • Kariniemi AL
        • Saarialho-Kere U
        • Kahari VM.
        Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck.
        Am J Pathol. 1997; 151: 499-508
        • Kusukawa J
        • Harada H
        • Shima I
        • Sasaguri Y
        • Kameyama T
        • Morimatsu M.
        The significance of epidermal growth factor receptor and matrix metalloproteinase-3 in squamous cell carcinoma of the oral cavity.
        Eur J Cancer B Oral Oncol. 1996; 32B: 217-221
        • Ramos DM
        • Chen B
        • Regezi J
        • Zardi L
        • Pytela R.
        Tenascin-C matrix assembly in oral squamous cell carcinoma.
        Int J Cancer. 1998; 75: 680-687
        • Lingen MW.
        Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents.
        Crit Rev Oral Biol Med. 1999; 10: 153-164
        • Myoken Y
        • Myoken Y
        • Okamoto T
        • Sato JD
        • Takada K.
        Immunocytochemical localization of fibroblast growth factor-1 (FGF-1) and FGF-2 in oral squamous cell carcinoma (SCC).
        J Oral Pathol Med. 1994; 23: 451-456
        • Mutirangura A
        • Supiyaphun P
        • Trirekapan S
        • Sriuranpong V
        • Sakuntabhai A
        • Yenrudi S
        • et al.
        Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma.
        Cancer Res. 1996; 56: 3530-3533
        • Sumida T
        • Sogawa K
        • Hamakawa H
        • Sugita A
        • Tanioka H
        • Ueda N.
        Detection of telomerase activity in oral lesions.
        J Oral Pathol Med. 1998; 27: 111-115
        • Coons AH
        • Creech HJ
        • Jones RN.
        Immunological properties of an antibody containing a fluorescent group.
        Proc Soc Exp Biol Med. 1941; 47: 200-202
        • Michel B
        • Milner Y
        • David K.
        Preservation of tissue-fixed immunoglobulins in skin biopsies of patients with lupus erythematosus and bullous diseases—preliminary report.
        J Invest Dermatol. 1972; 59: 449-452
        • Skeete MV
        • Black MM.
        The evaluation of a special liquid fixative for direct immunofluorescence.
        Clin Exp Dermatol. 1977; 2: 49-56
        • Vaughn Jones SA
        • Palmer I
        • Bhogal BS
        • Eady RA
        • Black MM.
        The use of Michel's transport medium for immunofluorescence and immunoelectron microscopy in autoimmune bullous diseases.
        J Cutan Pathol. 1995; 22: 365-370
        • Robinson JC
        • Lozada-Nur F
        • Frieden I.
        Oral pemphigus vulgaris: a review of the literature and a report on the management of 12 cases.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997; 84: 349-355
        • Beutner EH
        • Jordon RE.
        Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescent staining.
        Proc Soc Exp Biol Med. 1964; 117: 505-510
        • Beutner EH
        • Jordon RE
        • Chorzelski TP.
        The immunopathology of pemphigus and bullous pemphigoid.
        J Invest Dermatol. 1968; 51: 63-80
        • Dabelsteen E.
        Molecular biological aspects of acquired bullous diseases.
        Crit Rev Oral Biol Med. 1998; 9: 162-178
        • Stanley JR
        Pemphigus.
        in: 4th ed. Dermatology in general medicine. : McGraw-Hill Inc, New York1993: 606-615
        • Helander SD
        • Rogers III., RS
        The sensitivity and specificity of direct immunofluorescence testing in disorders of mucous membranes.
        J Am Acad Dermatol. 1994; 30: 65-75
        • Dayan S
        • Simmons RK
        • Ahmed AR.
        Contemporary issues in the diagnosis of oral pemphigoid: a selective review of the literature.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 88: 424-430
        • Scully C
        • Carrozzo M
        • Gandolfo S
        • Puiatti P
        • Monteil R.
        Update on mucous membrane pemphigoid: a heterogeneous immune-mediated subepithelial blistering entity.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999; 88: 56-68
        • Stanley JR.
        Bullous pemphigoid, cicatricial pemphigoid, and chronic bullous diseases in childhood.
        in: 4th ed. Dermatology in general medicine. : McGraw-Hill Inc, New York1993: 615-626
        • Yancey KB
        • Egan CA.
        Pemphigoid: clinical, histologic, immunopathologic, and therapeutic considerations.
        JAMA. 2000; 284: 350-356
        • Siegel MA
        • Anhalt GJ.
        Direct immunofluorescence of detached gingival epithelium for diagnosis of cicatricial pemphigoid. Report of five cases.
        Oral Surg Oral Med Oral Pathol. 1993; 75: 296-302
        • Cowan CG
        • Lamey PJ
        • Walsh M
        • Irwin ST
        • Allen G
        • McKenna KE.
        Linear IgA disease (LAD): immunoglobulin deposition in oral and colonic lesions.
        J Oral Pathol Med. 1995; 24: 374-378
        • Yih WY
        • Maier T
        • Kratochvil FJ
        • Zieper MB.
        Analysis of desquamative gingivitis using direct immunofluorescence in conjunction with histology.
        J Periodontol. 1998; 69: 678-685
        • Chan LS
        • Regezi JA
        • Cooper KD.
        Oral manifestations of linear IgA disease.
        J Am Acad Dermatol. 1990; 22: 362-365
        • Egan CA
        • Taylor TB
        • Meyer LJ
        • Petersen MJ
        • Zone JJ.
        The immunoglobulin A antibody response in clinical subsets of mucous membrane pemphigoid.
        Dermatology. 1999; 198: 3305
        • Scully C
        • Beyli M
        • Ferreiro MC
        • Ficarra G
        • Gill Y
        • Griffiths M
        • et al.
        Update on oral lichen planus: etiopathogenesis and management.
        Crit Rev Oral Biol Med. 1998; 9: 86-122
        • Daniels TE
        • Quadra-White C.
        Direct immunofluorescence in oral mucosal disease: a diagnostic analysis of 130 cases.
        Oral Surg Oral Med Oral Pathol. 1981; 51: 38-47
        • Firth NA
        • Rich AM
        • Radden BG
        • Reade PC.
        Assessment of the value of immunofluorescence microscopy in the diagnosis of oral mucosal lichen planus.
        J Oral Pathol Med. 1990; 19: 295-297
        • Schiødt M
        • Holmstrup P
        • Dabelsteen E
        • Ullman S.
        Deposits of immunoglobulins, complement, and fibrinogen in oral lupus erythematosus, lichen planus, and leukoplakia.
        Oral Surg Oral Med Oral Pathol. 1981; 51: 603-608
        • Church Jr, LF
        • Schosser RH.
        Chronic ulcerative stomatitis associated with stratified epithelial specific antinuclear antibodies. A case report of a newly described disease entity.
        Oral Surg Oral Med Oral Pathol. 1992; 73: 579-582
        • Lewis JE
        • Beutner EH
        • Rostami R
        • Chorzelski TP.
        Chronic ulcerative stomatitis with stratified epithelium-specific antinuclear antibodies.
        Int J Dermatol. 1996; 35: 272-275
        • Woodley DT
        • Briggaman RA
        • O'Keefe EJ
        • Inman AO
        • Queen LL
        • Gammon WR
        Identification of the skin basement-membrane autoantigen in epidermolysis bullosa acquisita.
        N Engl J Med. 1984; 310: 1007-1013
        • Jonkman MF
        • Schuur J
        • Dijk F
        • Heeres K
        • de Jong MC
        • van der Meer JB
        • et al.
        Inflammatory variant of epidermolysis bullosa acquisita with IgG autoantibodies against type VII collagen and laminin alpha3.
        Arch Dermatol. 2000; 136: 227-231
        • Nilsen R
        • Livden J
        • Thunold S.
        Oral lesions of epidermolysis bullosa acquisita.
        Oral Surg Oral Med Oral Pathol. 1978; 45: 749-754
        • Jaremko WM
        • Beutner EH
        • Kumar V
        • Kipping H
        • Condry P
        • Zeid MY
        • et al.
        Chronic ulcerative stomatitis associated with a specific immunologic marker.
        J Am Acad Dermatol. 1990; 22: 215-220
        • Beutner EH
        • Chorzelski TP
        • Parodi A
        • Schosser R
        • Guin J
        • Cardo PP
        • et al.
        Ten cases of chronic ulcerative stomatitis with stratified epithelium-specific antinuclear antibody.
        J Am Acad Dermatol. 1991; 24: 781-782
        • Chorzelski TP
        • Olszewska M
        • Jarzabek-Chorzelska M
        • Jablonska S.
        Is chronic ulcerative stomatitis an entity? Clinical and immunological findings in 18 cases.
        Eur J Dermatol. 1998; 8: 261-265
        • Lorenzana ER
        • Rees TD
        • Glass M
        • Detweiler JG.
        Chronic ulcerative stomatitis: a case report.
        J Periodontol. 2000; 71: 104-111